Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @VascularNews
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @VascularNews
-
Vascular News proslijedio/la je Tweet
Hospitals face “real challenge” of finding sensible solutions to treat CLI “epidemic” - https://bit.ly/3bgvLyz
@VSGBI@rebellvascular@CircFoundation@SimonNeequaye@ganan_sritharan@Jonnyboyle1@Colinbicknell@VascularSE@BSETnews@asgbi@DrMahim@CLIfighters@CLI_GlobalHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Enrolment of the VasQ external support US pivotal study now complete
#VascularNewshttp://ow.ly/ecXK30qf9I5Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
IVL has “changed the dynamics” of facilitating EVAR & TEVAR in calcified iliac arteries (Frank Arko) – https://bit.ly/2QDgdwQ
@ShockwaveIVL@VEITHsymposium#EVAR#IVL#TEVAR#iliac#calcificationHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Vascular News proslijedio/la je Tweet
Combination of scaffold and drug in BTK intervention “without question” the right way forward - https://bit.ly/37UZsTO
@VEITHsymposium@sahilparikhmd@derubertisMD@drbrowncares@ColumbiaPS@ColumbiaSurgery@ACCinTouch@SCAI@JillSommerset@DrPatGeraghty#AlwaysBLearningHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LINC2020: BD announced long-term safety data for BTK drug-coated balloon http://bit.ly/384YRzf#medicaldevice#VascularNewsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Centralisation of aortic surgery is “imperative” http://bit.ly/2GTvrYw
#VascularNews#aortic#surgeryHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Merit Medical’s EmboCube embolisation gelatin and Torpedo gelatin foam indicated for embolisation of blood vesselshttp://ow.ly/vhOM30qeApW
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LINC2020: Positive new data for AV access interventions released http://bit.ly/2v42erd#AVAccess#VascularNewsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Intact Vascular expands Tack Endovascular System portfolio offering http://bit.ly/2UgCLFM
#Endovascular#VascularNewsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LINC2020: Profusa Lumee oxygen platform may improve the clinical management of patients with CLI http://bit.ly/2GVpzxX#clinicalmanagement#VascularNewsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MedAlliance receives CE mark approval for SELUTION SLR sirolimus drug-eluting balloon for endovascular applicationshttp://ow.ly/aFxT30qeApy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LINC2020: High- and low-dose paclitaxel-coated balloons exhibit comparable results at one-year in COMPARE-RCT http://bit.ly/36PkkL3#paclitaxel#VascularNewsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#LINC2020: Four-year ILLUMENATE data reaffirm safety profile of Stellarex http://bit.ly/2RSfND3#VascularNews#medicaldataHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Katsanos responds to criticism of his new meta-analysis, summarised here https://vascularnews.com/meta-analysis-paclitaxel-katsanos/ …https://twitter.com/IN_publishing/status/1224298235382116352 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Peter Schneider: The prevalence of SAD and no-option CLTI is increasing; promising new alternatives are being explored, including deep venous arterialisation (DVA)
#LINC2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Marco Manzi: Foot artery canalisation is feasible and useful for wound healing in big artery disease (BAD) patients; small artery disease (SAD) patients “probably need a new approach”
#LINC2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First-in-man results with the WeFlow Arch: Benefit for lesions involving the arch and ascending aorta, cerebral blood flow affected at each step, but unsuitable for lesions with insufficient ascending landing zone
#LINC2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nick Inston: The WavelinQ EndoAVF system offers flexibility for dialysis patients’ future options
#LINC2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First time release of IN.PACT global 150mm data through three years: 74.5% freedom from CD-TLR and 87.5% freedom from all-cause death
#LINC2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
First time data release on the Turbo Power laser: Heterogeneous and restenotic lesions show greatest increase in MLA from baseline at high laser setting; might be the first step to develop a personalised algorithm to optimise treatment for each patient
#LINC2020Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.